INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.03 Million USD | 26.24% |
| 2022 | -10.89 Million USD | -63.68% |
| 2021 | -6.65 Million USD | 20.27% |
| 2020 | -8.34 Million USD | -285.1% |
| 2019 | -2.16 Million USD | 29.54% |
| 2018 | -3.07 Million USD | -338.09% |
| 2017 | -702.16 Thousand USD | 66.95% |
| 2016 | -2.12 Million USD | 57.17% |
| 2015 | -4.95 Million USD | -186.25% |
| 2014 | -1.73 Million USD | -127.75% |
| 2013 | -760.67 Thousand USD | -14.14% |
| 2012 | -666.45 Thousand USD | 16.43% |
| 2011 | -797.47 Thousand USD | -419.76% |
| 2010 | -153.43 Thousand USD | 96.71% |
| 2009 | -4.66 Million USD | -148.82% |
| 2008 | -1.87 Million USD | -4217.99% |
| 2007 | -43.38 Thousand USD | -487.41% |
| 2006 | -7386.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.59 Million USD | 19.97% |
| 2024 Q2 | -2.24 Million USD | -40.63% |
| 2023 Q4 | -1.99 Million USD | -59.78% |
| 2023 Q1 | -3.01 Million USD | -8.85% |
| 2023 Q2 | -2.24 Million USD | 25.61% |
| 2023 FY | -8.03 Million USD | 26.24% |
| 2023 Q3 | -1.24 Million USD | 44.28% |
| 2022 Q3 | -2.57 Million USD | 8.13% |
| 2022 FY | -10.89 Million USD | -63.68% |
| 2022 Q4 | -2.76 Million USD | -7.51% |
| 2022 Q1 | -2.84 Million USD | -1912.14% |
| 2022 Q2 | -2.8 Million USD | 1.62% |
| 2021 Q2 | -1.81 Million USD | 25.93% |
| 2021 Q3 | -2.24 Million USD | -23.42% |
| 2021 FY | -6.65 Million USD | 20.27% |
| 2021 Q4 | -141.52 Thousand USD | 93.69% |
| 2021 Q1 | -2.45 Million USD | 35.57% |
| 2020 FY | -8.34 Million USD | -285.1% |
| 2020 Q3 | -1.77 Million USD | -33.94% |
| 2020 Q4 | -3.8 Million USD | -114.93% |
| 2020 Q2 | -1.32 Million USD | 8.41% |
| 2020 Q1 | -1.44 Million USD | -90.78% |
| 2019 FY | -2.16 Million USD | 29.54% |
| 2019 Q2 | -241.55 Thousand USD | 47.32% |
| 2019 Q1 | -458.57 Thousand USD | 40.55% |
| 2019 Q3 | -710.33 Thousand USD | -194.07% |
| 2019 Q4 | -757.08 Thousand USD | -6.58% |
| 2018 Q3 | -294.86 Thousand USD | 84.19% |
| 2018 FY | -3.07 Million USD | -338.09% |
| 2018 Q1 | -144.72 Thousand USD | 28.17% |
| 2018 Q4 | -771.38 Thousand USD | -161.61% |
| 2018 Q2 | -1.86 Million USD | -1188.76% |
| 2017 Q4 | -201.46 Thousand USD | -35.35% |
| 2017 FY | -702.16 Thousand USD | 66.95% |
| 2017 Q3 | -148.84 Thousand USD | -8.67% |
| 2017 Q2 | -136.97 Thousand USD | 36.25% |
| 2017 Q1 | -214.87 Thousand USD | 22.26% |
| 2016 FY | -2.12 Million USD | 57.17% |
| 2016 Q4 | -276.4 Thousand USD | -31.11% |
| 2016 Q3 | -210.82 Thousand USD | 85.52% |
| 2016 Q2 | -1.45 Million USD | -702.88% |
| 2016 Q1 | -181.31 Thousand USD | 25.73% |
| 2015 Q4 | -244.12 Thousand USD | -98.16% |
| 2015 Q3 | -123.19 Thousand USD | 97.23% |
| 2015 Q1 | -144.65 Thousand USD | 0.0% |
| 2015 Q2 | -4.44 Million USD | -2974.33% |
| 2015 FY | -4.95 Million USD | -186.25% |
| 2014 FY | -1.73 Million USD | -127.75% |
| 2013 FY | -760.67 Thousand USD | -14.14% |
| 2012 FY | -666.45 Thousand USD | 16.43% |
| 2011 Q1 | -198.82 Thousand USD | 50.01% |
| 2011 Q2 | -306.91 Thousand USD | -54.37% |
| 2011 Q3 | -99.19 Thousand USD | 67.68% |
| 2011 Q4 | -192.53 Thousand USD | -94.09% |
| 2011 FY | -797.47 Thousand USD | -419.76% |
| 2010 FY | -153.43 Thousand USD | 96.71% |
| 2010 Q1 | 870.56 Thousand USD | 635.24% |
| 2010 Q4 | -397.74 Thousand USD | -69.12% |
| 2010 Q2 | -391.06 Thousand USD | -144.92% |
| 2010 Q3 | -235.19 Thousand USD | 39.86% |
| 2009 Q3 | -3.4 Million USD | -677.02% |
| 2009 Q1 | -651.05 Thousand USD | 64.47% |
| 2009 FY | -4.66 Million USD | -148.82% |
| 2009 Q4 | -162.65 Thousand USD | 95.23% |
| 2009 Q2 | -438.73 Thousand USD | 32.61% |
| 2008 Q3 | -13.34 Thousand USD | -38.56% |
| 2008 Q2 | -9632.00 USD | 46.01% |
| 2008 Q1 | -17.84 Thousand USD | 8.77% |
| 2008 Q4 | -1.83 Million USD | -13631.35% |
| 2008 FY | -1.87 Million USD | -4217.99% |
| 2007 FY | -43.38 Thousand USD | -487.41% |
| 2007 Q4 | -19.55 Thousand USD | -154.88% |
| 2007 Q2 | -12.97 Thousand USD | -307.09% |
| 2007 Q1 | -3186.00 USD | 0.0% |
| 2007 Q3 | -7673.00 USD | 40.84% |
| 2006 FY | -7386.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 90.161% |
| Cerus Corporation | -37.48 Million USD | 78.568% |
| OrthoPediatrics Corp. | -20.97 Million USD | 61.693% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 26.66% |
| Talis Biomedical Corporation | -62 Million USD | 87.042% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 40.848% |
| Inogen, Inc. | -102.44 Million USD | 92.157% |
| Spectral AI, Inc. | -20.85 Million USD | 61.472% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 86.78% |
| CVRx, Inc. | -41.19 Million USD | 80.498% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1355.024% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 9.213% |
| Orthofix Medical Inc. | -151.39 Million USD | 94.693% |
| Venus Concept Inc. | -37.25 Million USD | 78.431% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 86.961% |
| Bioventus Inc. | -156.23 Million USD | 94.857% |
| BrainsWay Ltd. | -4.19 Million USD | -91.437% |
| Envoy Medical, Inc. | -29.9 Million USD | 73.136% |
| electroCore, Inc. | -18.83 Million USD | 57.34% |
| IceCure Medical Ltd | -14.65 Million USD | 45.164% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 84.744% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 41.546% |
| MaxCyte, Inc. | -37.92 Million USD | 78.813% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 32.252% |
| Nexalin Technology, Inc. | -4.64 Million USD | -72.835% |
| PAVmed Inc | -64.17 Million USD | 87.48% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 84.686% |
| RxSight, Inc. | -48.6 Million USD | 83.471% |
| Sight Sciences, Inc. | -55.54 Million USD | 85.535% |
| SI-BONE, Inc. | -43.33 Million USD | 81.46% |
| TELA Bio, Inc. | -46.66 Million USD | 82.782% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 86.391% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 83.777% |
| LivaNova PLC | 17.54 Million USD | 145.792% |
| 908 Devices Inc. | -36.39 Million USD | 77.926% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 95.695% |
| Nemaura Medical Inc. | -14.14 Million USD | 43.193% |
| NeuroPace, Inc. | -32.95 Million USD | 75.62% |
| LENSAR, Inc. | -14.38 Million USD | 44.138% |
| Apyx Medical Corporation | -18.71 Million USD | 57.064% |
| Cutera, Inc. | -162.83 Million USD | 95.066% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 25.812% |
| BioSig Technologies, Inc. | -29.04 Million USD | 72.334% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 90.281% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 63.626% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 111.861% |
| Axonics, Inc. | -6.08 Million USD | -31.975% |
| Outset Medical, Inc. | -172.79 Million USD | 95.35% |
| IRIDEX Corporation | -9.57 Million USD | 16.044% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 92.413% |
| IRadimed Corporation | 17.19 Million USD | 146.732% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 2.54% |
| Telesis Bio, Inc. | -47.72 Million USD | 83.164% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 178.44% |
| Varex Imaging Corporation | -47.7 Million USD | 83.156% |
| Quipt Home Medical Corp. | -2.78 Million USD | -188.6% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 28.809% |
| Pulmonx Corporation | -60.84 Million USD | 86.795% |
| Dynatronics Corporation | -2.69 Million USD | -197.83% |
| Modular Medical, Inc. | -17.47 Million USD | 54.009% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 29.44% |
| Semler Scientific, Inc. | 20.58 Million USD | 139.035% |
| InMode Ltd. | 197.91 Million USD | 104.06% |
| Bruker Corporation | 427.2 Million USD | 101.881% |
| Cytosorbents Corporation | -28.5 Million USD | 71.816% |
| DexCom, Inc. | 541.5 Million USD | 101.484% |
| Align Technology, Inc. | 445.05 Million USD | 101.805% |
| Viveve Medical, Inc. | -22.02 Million USD | 63.524% |
| ZimVie Inc. | -393.28 Million USD | 97.957% |
| Movano Inc. | -29.28 Million USD | 72.562% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 33.861% |
| Nexalin Technology, Inc. | -4.64 Million USD | -72.835% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1355.024% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 96.391% |
| Profound Medical Corp. | -28.56 Million USD | 71.876% |
| Insulet Corporation | 206.3 Million USD | 103.895% |
| enVVeno Medical Corporation | -23.51 Million USD | 65.833% |
| Surmodics, Inc. | -11.54 Million USD | 30.388% |
| iCAD, Inc. | -4.84 Million USD | -65.765% |
| Nuwellis, Inc. | -20.2 Million USD | 60.242% |
| Biotricity, Inc. | -14.09 Million USD | 42.994% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 93.489% |
| Aethlon Medical, Inc. | -12.2 Million USD | 34.187% |
| InspireMD, Inc. | -19.91 Million USD | 59.658% |
| PAVmed Inc. | -64.17 Million USD | 87.48% |
| BIOLASE, Inc. | -20.63 Million USD | 61.058% |
| Beyond Air, Inc. | -60.24 Million USD | 86.663% |
| FONAR Corporation | 10.56 Million USD | 176.032% |
| AxoGen, Inc. | -21.71 Million USD | 63.001% |
| Vivani Medical, Inc. | -25.65 Million USD | 68.678% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 128.177% |
| Inari Medical, Inc. | -1.63 Million USD | -391.113% |
| UFP Technologies, Inc. | 44.92 Million USD | 117.885% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -56.549% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -21.641% |
| Tenon Medical, Inc. | -15.58 Million USD | 48.433% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 47.915% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 77.26% |
| AdaptHealth Corp. | -678.89 Million USD | 98.817% |
| Sintx Technologies, Inc. | -8.25 Million USD | 2.717% |
| NanoVibronix, Inc. | -3.71 Million USD | -116.508% |
| Quanterix Corporation | -32.33 Million USD | 75.151% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 28.809% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1756.621% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 97.381% |
| TransMedics Group, Inc. | -25.02 Million USD | 67.898% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 63.698% |
| NeuroMetrix, Inc. | -6.52 Million USD | -23.051% |
| Hyperfine, Inc. | -44.23 Million USD | 81.838% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 89.765% |
| Biomerica, Inc. | -5.97 Million USD | -34.403% |
| Bone Biologics Corporation | -8.94 Million USD | 10.215% |
| AVITA Medical, Inc. | -39.16 Million USD | 79.487% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 19.282% |
| Silk Road Medical, Inc | -55.74 Million USD | 85.586% |